Pharma Foods International Co., Ltd. (2929.T)
JPY 934.0
(-0.43%)
JPY 934.0
(-0.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 48.75 Billion JPY | -11.81% |
| 2023 | 55.27 Billion JPY | 14.91% |
| 2022 | 48.1 Billion JPY | 21.1% |
| 2021 | 39.72 Billion JPY | 226.28% |
| 2020 | 12.17 Billion JPY | 42.62% |
| 2019 | 8.53 Billion JPY | 34.4% |
| 2018 | 6.35 Billion JPY | 70.9% |
| 2017 | 3.71 Billion JPY | 51.14% |
| 2016 | 2.45 Billion JPY | 78.39% |
| 2015 | 1.37 Billion JPY | 52.75% |
| 2014 | 902.37 Million JPY | 0.98% |
| 2013 | 893.58 Million JPY | 57.68% |
| 2012 | 566.72 Million JPY | 35.77% |
| 2011 | 417.41 Million JPY | -5.83% |
| 2010 | 443.23 Million JPY | 80.77% |
| 2009 | 245.19 Million JPY | -11.19% |
| 2008 | 276.07 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 12.71 Billion JPY | -1.97% |
| 2024 Q4 | 11.45 Billion JPY | -6.02% |
| 2024 Q2 | 12.34 Billion JPY | -2.95% |
| 2024 Q3 | 12.18 Billion JPY | -1.3% |
| 2023 FY | 55.27 Billion JPY | 14.91% |
| 2023 Q2 | 14.56 Billion JPY | 5.32% |
| 2023 Q4 | 12.97 Billion JPY | -6.8% |
| 2023 Q1 | 13.82 Billion JPY | 7.29% |
| 2023 Q3 | 13.91 Billion JPY | -4.41% |
| 2022 Q4 | 12.88 Billion JPY | 5.74% |
| 2022 FY | 48.1 Billion JPY | 21.1% |
| 2022 Q3 | 12.18 Billion JPY | -1.3% |
| 2022 Q2 | 12.34 Billion JPY | 15.52% |
| 2022 Q1 | 10.68 Billion JPY | -3.18% |
| 2021 Q2 | 10.24 Billion JPY | 45.41% |
| 2021 FY | 39.72 Billion JPY | 226.28% |
| 2021 Q4 | 11.03 Billion JPY | -3.12% |
| 2021 Q3 | 11.39 Billion JPY | 11.22% |
| 2021 Q1 | 7.04 Billion JPY | 109.89% |
| 2020 FY | 12.17 Billion JPY | 42.62% |
| 2020 Q4 | 3.35 Billion JPY | -9.21% |
| 2020 Q3 | 3.69 Billion JPY | 35.37% |
| 2020 Q1 | 2.38 Billion JPY | 15.18% |
| 2020 Q2 | 2.73 Billion JPY | 14.32% |
| 2019 Q2 | 2.14 Billion JPY | 1.84% |
| 2019 FY | 8.53 Billion JPY | 34.4% |
| 2019 Q4 | 2.07 Billion JPY | -6.16% |
| 2019 Q1 | 2.1 Billion JPY | 32.73% |
| 2019 Q3 | 2.21 Billion JPY | 3.06% |
| 2018 Q4 | 1.58 Billion JPY | -12.61% |
| 2018 Q2 | 1.65 Billion JPY | 27.71% |
| 2018 Q1 | 1.29 Billion JPY | 27.57% |
| 2018 FY | 6.35 Billion JPY | 70.9% |
| 2018 Q3 | 1.81 Billion JPY | 9.83% |
| 2017 Q3 | 1.12 Billion JPY | 23.19% |
| 2017 FY | 3.71 Billion JPY | 51.14% |
| 2017 Q4 | 1.01 Billion JPY | -9.55% |
| 2017 Q2 | 910.88 Million JPY | 36.27% |
| 2017 Q1 | 668.46 Million JPY | 0.56% |
| 2016 FY | 2.45 Billion JPY | 78.39% |
| 2016 Q2 | 732.05 Million JPY | 68.61% |
| 2016 Q1 | 434.16 Million JPY | -19.06% |
| 2016 Q3 | 627.94 Million JPY | -14.22% |
| 2016 Q4 | 664.74 Million JPY | 5.86% |
| 2015 Q3 | 334.57 Million JPY | 1.23% |
| 2015 Q2 | 330.52 Million JPY | 86.87% |
| 2015 Q1 | 176.87 Million JPY | -49.89% |
| 2015 FY | 1.37 Billion JPY | 52.75% |
| 2015 Q4 | 536.38 Million JPY | 60.32% |
| 2014 Q4 | 352.94 Million JPY | 132.47% |
| 2014 Q1 | 188.04 Million JPY | -53.11% |
| 2014 FY | 902.37 Million JPY | 0.98% |
| 2014 Q2 | 209.55 Million JPY | 11.44% |
| 2014 Q3 | 151.82 Million JPY | -27.55% |
| 2013 FY | 893.58 Million JPY | 57.68% |
| 2013 Q1 | 211.01 Million JPY | -28.69% |
| 2013 Q2 | 125.49 Million JPY | -40.53% |
| 2013 Q3 | 156.05 Million JPY | 24.35% |
| 2013 Q4 | 401.02 Million JPY | 156.98% |
| 2012 Q4 | 295.9 Million JPY | 186.88% |
| 2012 FY | 566.72 Million JPY | 35.77% |
| 2012 Q2 | 79.81 Million JPY | -9.16% |
| 2012 Q3 | 103.14 Million JPY | 29.23% |
| 2012 Q1 | 87.86 Million JPY | -42.51% |
| 2011 Q2 | 92.77 Million JPY | 70.76% |
| 2011 FY | 417.41 Million JPY | -5.83% |
| 2011 Q4 | 152.81 Million JPY | 30.06% |
| 2011 Q3 | 117.49 Million JPY | 26.65% |
| 2011 Q1 | 54.32 Million JPY | -56.22% |
| 2010 Q2 | 132.62 Million JPY | 81.2% |
| 2010 FY | 443.23 Million JPY | 80.77% |
| 2010 Q1 | 73.19 Million JPY | 42.45% |
| 2010 Q4 | 124.09 Million JPY | 9.5% |
| 2010 Q3 | 113.33 Million JPY | -14.54% |
| 2009 Q4 | 51.38 Million JPY | -10.05% |
| 2009 Q3 | 57.12 Million JPY | -24.86% |
| 2009 Q1 | 60.67 Million JPY | 0.0% |
| 2009 FY | 245.19 Million JPY | -11.19% |
| 2009 Q2 | 76.01 Million JPY | 25.29% |
| 2008 FY | 276.07 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 97.769% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 74.065% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 86.791% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -1276.845% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 49.749% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -27.55% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 91.686% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -712.804% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 38.266% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 6.372% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -260.672% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -530.034% |
| Tsumura & Co. | 68.81 Billion JPY | 29.157% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -30.559% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -96.644% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 40.096% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -195.198% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 2.848% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 5.152% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -4418.258% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -395.498% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1005.233% |
| MedRx Co., Ltd | 26 Million JPY | -187407.692% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -507.447% |
| Solasia Pharma K.K. | 337 Million JPY | -14366.469% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 6669320.246% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -58.983% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 10.249% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -129064.9% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 56.851% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -634.261% |